Slingshot members are tracking this event:
FDA's Advisory Committee Votes in Favor of Approval of Merck's (MRK) Muscle Relaxant Reversal Agent BRIDION
Slingshot Insights Explained
Nov 06, 2015
Don’t see a project related to the catalyst you care about?
Related Keywords Sugammadex, Bridion, Reversal Agent For Muscle Relaxants, Adcom